Oppenheimer & Co’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,048
Closed -$210K 1585
2021
Q2
$210K Buy
+4,048
New +$203K ﹤0.01% 1405
2020
Q4
Sell
-4,631
Closed -$201K 1415
2020
Q3
$201K Sell
4,631
-390
-8% -$17.1K 0.01% 1159
2020
Q2
$216K Buy
+5,021
New +$208K 0.01% 1090
2018
Q4
Sell
-4,114
Closed -$200K 1375
2018
Q3
$200K Sell
4,114
-1,866
-31% -$88.4K 0.01% 1232
2018
Q2
$257K Sell
5,980
-142
-2% -$5.96K 0.01% 1123
2018
Q1
$256K Sell
6,122
-3,356
-35% -$146K 0.01% 1122
2017
Q4
$413K Sell
9,478
-97
-1% -$4.13K 0.01% 935
2017
Q3
$407K Buy
9,575
+1,412
+17% +$59.9K 0.01% 924
2017
Q2
$351K Buy
8,163
+745
+10% +$31.4K 0.01% 967
2017
Q1
$310K Buy
7,418
+1,401
+23% +$57.1K 0.01% 985
2016
Q4
$235K Buy
6,017
+1,433
+31% +$58.3K 0.01% 1097
2016
Q3
$203K Buy
+4,584
New +$208K 0.01% 1138
2016
Q1
Sell
-4,848
Closed -$248K 1331
2015
Q4
$248K Sell
4,848
-2,928
-38% -$149K 0.01% 1030
2015
Q3
$364K Buy
7,776
+3,336
+75% +$201K 0.01% 924
2015
Q2
$276K Buy
4,440
+48
+1% +$2.99K 0.01% 1129
2015
Q1
$271K Sell
4,392
-354
-7% -$21K 0.01% 1142
2014
Q4
$256K Sell
4,746
-454
-9% -$24.8K 0.01% 1097
2014
Q3
$275K Buy
5,200
+850
+20% +$43.2K 0.01% 1110
2014
Q2
$226K Sell
4,350
-672
-13% -$32.4K 0.01% 1199
2014
Q1
$235K Sell
5,022
-60
-1% -$2.83K 0.01% 1159
2013
Q4
$224K Buy
+5,082
New +$212K 0.01% 1159

Other funds holding XPH